{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:56:21Z","timestamp":1757620581326,"version":"3.44.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\"Setting Sail for Youth Scientific Research\" -Youth Foundation of the First Affiliated Hospital of Xinjiang Medical University","award":["2023YFY-QKQN-60","2023YFY-QKQN-60","2023YFY-QKQN-60","2023YFY-QKQN-60","2023YFY-QKQN-60"],"award-info":[{"award-number":["2023YFY-QKQN-60","2023YFY-QKQN-60","2023YFY-QKQN-60","2023YFY-QKQN-60","2023YFY-QKQN-60"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07405-x","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T07:36:05Z","timestamp":1753947365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of lipid accumulation product in patients with type 2 diabetes mellitus and heart failure with reduced ejection fraction: a retrospective cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Hao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"18","key":"7405_CR1","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"issue":"30","key":"7405_CR2","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1093\/eurheartj\/ehy354","volume":"39","author":"M Packer","year":"2018","unstructured":"Packer M. Questioning the obvious: does dyspnoea really matter in heart failure. Eur Heart J. 2018;39(30):2822\u20134.","journal-title":"Eur Heart J"},{"issue":"10258","key":"7405_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"5","key":"7405_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jama.2020.10262","volume":"324","author":"SP Murphy","year":"2020","unstructured":"Murphy SP, Ibrahim NE, Januzzi JL Jr. Heart failure with reduced ejection fraction: a review. JAMA. 2020;324(5):488\u2013504.","journal-title":"JAMA"},{"issue":"21","key":"7405_CR5","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"J McMurray","year":"2019","unstructured":"McMurray J, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995\u20132008.","journal-title":"N Engl J Med"},{"issue":"6","key":"7405_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","volume":"113","author":"T Doenst","year":"2013","unstructured":"Doenst T, Nguyen TD, Abel ED. Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res. 2013;113(6):709\u201324.","journal-title":"Circ Res"},{"issue":"7","key":"7405_CR7","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","volume":"140","author":"SM Dunlay","year":"2019","unstructured":"Dunlay SM, Givertz MM, Aguilar D, et al. Type 2 diabetes mellitus and heart failure: a scientific statement from the American heart association and the heart failure society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update. Circulation. 2019;140(7):e294\u2013324.","journal-title":"Circulation"},{"issue":"15","key":"7405_CR8","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413\u201324.","journal-title":"N Engl J Med"},{"issue":"1","key":"7405_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12933-022-01660-z","volume":"21","author":"H Deng","year":"2022","unstructured":"Deng H, Hu P, Li H, et al. Novel lipid indicators and the risk of type 2 diabetes mellitus among Chinese hypertensive patients: findings from the Guangzhou Heart Study. Cardiovasc Diabetol. 2022;21(1):212.","journal-title":"Cardiovasc Diabetol"},{"key":"7405_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2261-5-26","volume":"5","author":"HS Kahn","year":"2005","unstructured":"Kahn HS. The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"7405_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jdi.12842","volume":"10","author":"A Kanda","year":"2019","unstructured":"Kanda A, Ishida S. (Pro)renin receptor: Involvement in diabetic retinopathy and development of molecular targeted therapy. J Diabetes Investig. 2019;10(1):6\u201317.","journal-title":"J Diabetes Investig"},{"issue":"7","key":"7405_CR12","first-page":"860","volume":"33","author":"KA De Jong","year":"2017","unstructured":"De Jong KA, Lopaschuk GD. Complex energy metabolic changes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Can J Cardiol. 2017;33(7):860\u201371.","journal-title":"Can J Cardiol"},{"issue":"1","key":"7405_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al. 2. classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46(1):19\u201340.","journal-title":"Diabetes Care"},{"issue":"17","key":"7405_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013114","volume":"8","author":"J Yap","year":"2019","unstructured":"Yap J, Tay WT, Teng TK, et al. Association of diabetes mellitus on cardiac remodeling, quality of life, and clinical outcomes in heart failure with reduced and preserved ejection fraction. J Am Heart Assoc. 2019;8(17): e013114.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"7405_CR15","doi-asserted-by":"publisher","first-page":"11664","DOI":"10.1038\/s41598-021-91170-x","volume":"11","author":"S Kwak","year":"2021","unstructured":"Kwak S, Hwang IC, Park JJ, Park JH, Park JB, Cho GY. Sex-specific impact of diabetes mellitus on left ventricular systolic function and prognosis in heart failure. Sci Rep. 2021;11(1):11664.","journal-title":"Sci Rep"},{"issue":"6","key":"7405_CR16","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1530\/EJE-11-0687","volume":"165","author":"NF Ehl","year":"2011","unstructured":"Ehl NF, K\u00fchne M, Brinkert M, M\u00fcller-Brand J, Zellweger MJ. Diabetes reduces left ventricular ejection fraction\u2013irrespective of presence and extent of coronary artery disease. Eur J Endocrinol. 2011;165(6):945\u201351.","journal-title":"Eur J Endocrinol"},{"issue":"13","key":"7405_CR17","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.3390\/ijms25137319","volume":"25","author":"T Takata","year":"2024","unstructured":"Takata T, Inoue S, Masauji T, Miyazawa K, Motoo Y. Generation and accumulation of various advanced glycation end-products in cardiomyocytes may induce cardiovascular disease. Int J Mol Sci. 2024;25(13):7319.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7405_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4093\/dmj.2017.0105","volume":"42","author":"SY Rhee","year":"2018","unstructured":"Rhee SY, Kim YS. The role of advanced glycation end products in diabetic vascular complications. Diabetes Metab J. 2018;42(3):188\u201395.","journal-title":"Diabetes Metab J"},{"issue":"1","key":"7405_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12933-019-0865-6","volume":"18","author":"M Kozakova","year":"2019","unstructured":"Kozakova M, Morizzo C, Goncalves I, Natali A, Nilsson J, Palombo C. Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation. Cardiovasc Diabetol. 2019;18(1):61.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"7405_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-018-0042-6","volume":"40","author":"M Knapp","year":"2019","unstructured":"Knapp M, Tu X, Wu R. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol Sin. 2019;40(1):1\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"18","key":"7405_CR21","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2174\/1381612825666190708192134","volume":"25","author":"N Katsiki","year":"2019","unstructured":"Katsiki N, Anagnostis P, Kotsa K, Goulis DG, Mikhailidis DP. Obesity, metabolic syndrome and the risk of microvascular complications in patients with diabetes mellitus. Curr Pharm Des. 2019;25(18):2051\u20139.","journal-title":"Curr Pharm Des"},{"issue":"10","key":"7405_CR22","first-page":"316","volume":"11","author":"KA Papathanasiou","year":"2024","unstructured":"Papathanasiou KA, Roussos CE, Armylagos S, Rallidis SL, Rallidis LS. Lipid accumulation product is predictive of cardiovascular hospitalizations among patients with stable ischemic heart disease: long-term follow-up of the LAERTES study. J Cardiovasc Dev Dis. 2024;11(10):316.","journal-title":"J Cardiovasc Dev Dis"},{"key":"7405_CR23","doi-asserted-by":"publisher","first-page":"1277162","DOI":"10.3389\/fendo.2023.1277162","volume":"14","author":"J Mao","year":"2023","unstructured":"Mao J, Gan S, Zhou Q, et al. Positive correlation between lipid accumulation product index and arterial stiffness in Chinese patients with type 2 diabetes. Front Endocrinol (Lausanne). 2023;14:1277162.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"7405_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-020-0989-8","volume":"19","author":"Z Qin","year":"2020","unstructured":"Qin Z, Zhou K, Li Y, et al. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):23.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"7405_CR25","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.3390\/jcm13102843","volume":"13","author":"S Tamini","year":"2024","unstructured":"Tamini S, Bondesan A, Caroli D, Sartorio A. The Lipid accumulation product index (LAP) and the cardiometabolic index (CMI) are useful for predicting the presence and severity of metabolic syndrome in adult patients with obesity. J Clin Med. 2024;13(10):2843.","journal-title":"J Clin Med"},{"issue":"8","key":"7405_CR26","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.jdiacomp.2016.07.011","volume":"30","author":"BA de Souza","year":"2016","unstructured":"de Souza BA, Graves DT, de Melo Loureiro AP, et al. Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients. J Diabetes Complications. 2016;30(8):1593\u20139.","journal-title":"J Diabetes Complications"},{"issue":"23","key":"7405_CR27","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.109.830984","volume":"120","author":"RS Velagaleti","year":"2009","unstructured":"Velagaleti RS, Massaro J, Vasan RS, Robins SJ, Kannel WB, Levy D. Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study. Circulation. 2009;120(23):2345\u201351.","journal-title":"Circulation"},{"issue":"2","key":"7405_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/ajcn\/nqaa331","volume":"113","author":"L Wang","year":"2021","unstructured":"Wang L, Lee Y, Wu Y, et al. A prospective study of waist circumference trajectories and incident cardiovascular disease in China: the Kailuan Cohort Study. Am J Clin Nutr. 2021;113(2):338\u201347.","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"7405_CR29","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/j.1464-5491.2011.03318.x","volume":"28","author":"AM Wassink","year":"2011","unstructured":"Wassink AM, van der Graaf Y, van Haeften TW, et al. Waist circumference and metabolic risk factors have separate and additive effects on the risk of future Type 2 diabetes in patients with vascular diseases. A cohort study Diabet Med. 2011;28(8):932\u201340.","journal-title":"A cohort study Diabet Med"},{"issue":"6","key":"7405_CR30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3343\/alm.2015.35.6.586","volume":"35","author":"Y Cho","year":"2015","unstructured":"Cho Y, Lee SG, Jee SH, Kim JH. Hypertriglyceridemia is a major factor associated with elevated levels of small dense LDL cholesterol in patients with metabolic syndrome. Ann Lab Med. 2015;35(6):586\u201394.","journal-title":"Ann Lab Med"},{"key":"7405_CR31","first-page":"1530","volume":"6","author":"G Huangfu","year":"2025","unstructured":"Huangfu G, Chan DC, Pang J, et al. Triglyceride to high-density lipoprotein cholesterol ratio as a marker of subclinical coronary atherosclerosis and hepatic steatosis in familial hypercholesterolemia. Endocr Pract. 2025;6:1530\u2013891.","journal-title":"Endocr Pract"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07405-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07405-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07405-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:50:55Z","timestamp":1757321455000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07405-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7405"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07405-x","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University (Approval No. 240104-02). All procedures adhered to the ethical principles of the Declaration of Helsinki. Written informed consent was obtained from all participants prior to inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Participants provided written informed consent for anonymized data usage in research publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"335"}}